182 related articles for article (PubMed ID: 22881720)
1. Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy.
Kang CS; Sun X; Jia F; Song HA; Chen Y; Lewis M; Chong HS
Bioconjug Chem; 2012 Sep; 23(9):1775-82. PubMed ID: 22881720
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies.
Kang CS; Song HA; Milenic DE; Baidoo KE; Brechbiel MW; Chong HS
Nucl Med Biol; 2013 Jul; 40(5):600-5. PubMed ID: 23541026
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
Kang CS; Chen Y; Lee H; Liu D; Sun X; Kweon J; Lewis MR; Chong HS
Nucl Med Biol; 2015 Mar; 42(3):242-9. PubMed ID: 25487552
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of (90)Y and (177)Lu.
Chong HS; Sun X; Chen Y; Sin I; Kang CS; Lewis MR; Liu D; Ruthengael VC; Zhong Y; Wu N; Song HA
Bioorg Med Chem; 2015 Mar; 23(5):1169-78. PubMed ID: 25648683
[TBL] [Abstract][Full Text] [Related]
5. Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
Chong HS; Song HA; Ma X; Milenic DE; Brady ED; Lim S; Lee H; Baidoo K; Cheng D; Brechbiel MW
Bioconjug Chem; 2008 Jul; 19(7):1439-47. PubMed ID: 18564868
[TBL] [Abstract][Full Text] [Related]
6. Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted α-radioimmunotherapy applications.
Song HA; Kang CS; Baidoo KE; Milenic DE; Chen Y; Dai A; Brechbiel MW; Chong HS
Bioconjug Chem; 2011 Jun; 22(6):1128-35. PubMed ID: 21604692
[TBL] [Abstract][Full Text] [Related]
7. Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
Chong HS; Ma X; Le T; Kwamena B; Milenic DE; Brady ED; Song HA; Brechbiel MW
J Med Chem; 2008 Jan; 51(1):118-25. PubMed ID: 18062661
[TBL] [Abstract][Full Text] [Related]
8. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
9. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
Price EW; Zeglis BM; Lewis JS; Adam MJ; Orvig C
Dalton Trans; 2014 Jan; 43(1):119-31. PubMed ID: 24104523
[TBL] [Abstract][Full Text] [Related]
10. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
11. 3p-C-NETA: A versatile and effective chelator for development of Al
Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
[No Abstract] [Full Text] [Related]
12. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
Chong HS; Milenic DE; Garmestani K; Brady ED; Arora H; Pfiester C; Brechbiel MW
Nucl Med Biol; 2006 May; 33(4):459-67. PubMed ID: 16720237
[TBL] [Abstract][Full Text] [Related]
13. Efficient synthesis and evaluation of bimodal ligand NETA.
Chong HS; Song HA; Birch N; Le T; Lim S; Ma X
Bioorg Med Chem Lett; 2008 Jun; 18(11):3436-9. PubMed ID: 18445528
[TBL] [Abstract][Full Text] [Related]
14. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates.
Dadwal M; Kang CS; Song HA; Sun X; Dai A; Baidoo KE; Brechbiel MW; Chong HS
Bioorg Med Chem Lett; 2011 Dec; 21(24):7513-5. PubMed ID: 22047687
[TBL] [Abstract][Full Text] [Related]
16. Preparation of
Pandey U; Kameswaran M; Gamre N; Dash A
J Labelled Comp Radiopharm; 2019 Apr; 62(4):158-165. PubMed ID: 30663095
[TBL] [Abstract][Full Text] [Related]
17. A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
Price EW; Edwards KJ; Carnazza KE; Carlin SD; Zeglis BM; Adam MJ; Orvig C; Lewis JS
Nucl Med Biol; 2016 Sep; 43(9):566-576. PubMed ID: 27419360
[TBL] [Abstract][Full Text] [Related]
18. H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.
Price EW; Zeglis BM; Cawthray JF; Ramogida CF; Ramos N; Lewis JS; Adam MJ; Orvig C
J Am Chem Soc; 2013 Aug; 135(34):12707-21. PubMed ID: 23901833
[TBL] [Abstract][Full Text] [Related]
19. New Bifunctional Chelator 3p-
Sun X; Kang CS; Sin I; Zhang S; Ren S; Wang H; Liu D; Lewis MR; Chong HS
ACS Omega; 2020 Nov; 5(44):28615-28620. PubMed ID: 33195913
[TBL] [Abstract][Full Text] [Related]
20. Clinical Dose Preparation of [
Menon SR; Mitra A; Chakraborty A; Tawate M; Sahu S; Rakshit S; Gaikwad S; Dhotre G; Damle A; Banerjee S
Cancer Biother Radiopharm; 2022 Jun; 37(5):384-402. PubMed ID: 35575711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
